Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06025331 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?

Study acronym: CARS-1
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 2
    v3
  2. Start date: Aug 28, 2023 to Sep 15, 2023v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to compare two different types of reverse shoulder replacements. Researchers will compare a conventional reverse shoulder replacement with a lateralized reverse shoulder replacement to see if there is a difference in how well the patients function after two years.
Trial Details
NCT Number NCT06025331
Lead Sponsor Lovisenberg Diakonale Hospital
Collaborators: Haukeland University Hospital, Sykehuset Telemark, University Hospital, Akershus
Conditions
(from sponsor)		 Arthroplasty, Replacement, Shoulder, Shoulder Osteoarthritis
Enrollment 130 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov